|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/29 | |
| A61K 33/10 | |||
| A61P 19/08 | |||
| A61P 19/10 | |||
| A61P 43/00 |
| (11) | Patento numeris | 2476429 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10815369.3 |
| Europos patento paraiškos padavimo data | 2010-09-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-07-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-03-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2010/065379 |
| Data | 2010-09-08 |
| (87) | Numeris | WO 2011/030774 |
| Data | 2011-03-17 |
| (30) | Numeris | Data | Šalis |
| 2009208039 | 2009-09-09 | JP |
| (72) |
SHIRAE Shinichiro, JP
NAKAMURA Yasuo, JP
OYA, Yuiko, JP
NOZAKI Yoshihide, JP
KOBAYASHI Nobuyuki, JP
KURODA Tatsuhiko, JP
KATO Hiroki, JP
SERADA Masashi, JP
HORI Kazuyoshi, JP
|
| (73) |
Asahi Kasei Pharma Corporation,
1-105 Kanda Jinbocho Chiyoda-ku, Tokyo 101-8101,
JP
|
| (54) | PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK AT UNIT DOSE OF 200 UNITS |
| PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK AT UNIT DOSE OF 200 UNITS |